Literature DB >> 23598596

Effect of intensive glycaemic control on endothelial progenitor cells in patients with long-standing uncontrolled type 2 diabetes.

Eli I Lev1, Joel Singer2, Dorit Leshem-Lev3, Merav Rigler2, Oshrat Dadush3, Muthiah Vaduganathan4, Alexander Battler5, Ran Kornowski5.   

Abstract

AIMS: Endothelial progenitor cells (EPCs) have an important role in repair following vascular injury. However, in patients with diabetes, EPC number and function are markedly reduced. It is unclear whether intensive glycaemic control can modify EPC properties in diabetic patients. We aimed to examine whether glycaemic control can improve EPC number and function in patients with long-standing uncontrolled type 2 diabetes. METHODS AND
RESULTS: Thirty-five patients with treated type 2 diabetes and HgA1c ≥ 8.5% were included. Patients were tested at baseline and after 3-4 months of an intensive glycaemic control programme, with the aim of achieving HgA1c of 7%. The diabetes group was compared to 20 patients without diabetes (control). Circulating EPC levels were assessed by flow cytometry for expression of VEGFR2, CD133, and CD34. The capacity of the cells to form colony-forming units (CFUs), and their migration and viability were quantified after 1 week of culture. Patients with diabetes (mean age 61.1 ± 7 years, 28.6% women, disease duration of 19.2 ± 8 years) had a baseline HgA1c of 9.4 ± 0.8%. After the glycaemic control period, HgA1c decreased to 8 ± 0.8%. Circulating EPC levels increased significantly after the intensive control period and reached a level similar to the control group. The number of EPC CFUs also increased significantly after glycaemic control but remained lower than the control group. All EPC functional assays improved following the glycaemic control.
CONCLUSIONS: In patients with uncontrolled long-standing type 2 diabetes, intensive glycaemic control was associated with an increase in the levels of circulating EPCs, and improvement in their functional properties. © The European Society of Cardiology 2013 Reprints and permissions:sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Diabetes; endothelial progenitor cells; glycaemic control

Mesh:

Substances:

Year:  2013        PMID: 23598596     DOI: 10.1177/2047487313488300

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  8 in total

1.  Pathways mediating the interaction between endothelial progenitor cells (EPCs) and platelets.

Authors:  Oshrat Raz; Dorit L Lev; Alexander Battler; Eli I Lev
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

2.  Effect of vitamin D on endothelial progenitor cells function.

Authors:  Yoav Hammer; Alissa Soudry; Amos Levi; Yeela Talmor-Barkan; Dorit Leshem-Lev; Joel Singer; Ran Kornowski; Eli I Lev
Journal:  PLoS One       Date:  2017-05-17       Impact factor: 3.240

3.  Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: a 12-month randomized controlled trial in patients with type 2 diabetes.

Authors:  Alessandra Dei Cas; Valentina Spigoni; Monia Cito; Raffaella Aldigeri; Valentina Ridolfi; Elisabetta Marchesi; Michela Marina; Eleonora Derlindati; Rosalia Aloe; Riccardo C Bonadonna; Ivana Zavaroni
Journal:  Cardiovasc Diabetol       Date:  2017-02-23       Impact factor: 9.951

4.  Reduced Vitamin D Receptor on Circulating Endothelial Progenitor Cells: A New Risk Factor of Coronary Artery Diseases.

Authors:  Sidi Ai; Zhiqing He; Ru Ding; Feng Wu; Zhigang Huang; Jiamei Wang; Shuaibo Huang; Xianliang Dai; Jiayou Zhang; Jing Chen; Linlin Liu; Zonggui Wu; Chun Liang
Journal:  J Atheroscler Thromb       Date:  2017-11-24       Impact factor: 4.928

5.  Platelets of Healthy Origins Promote Functional Improvement of Atherosclerotic Endothelial Progenitor Cells.

Authors:  Nicoleta Alexandru; Florentina Safciuc; Alina Constantin; Miruna Nemecz; Gabriela Tanko; Alexandru Filippi; Emanuel Dragan; Elisabeta Bãdilã; Adriana Georgescu
Journal:  Front Pharmacol       Date:  2019-04-24       Impact factor: 5.810

6.  Dysfunctional endothelial progenitor cells in patients with Hodgkin's lymphoma in complete remission.

Authors:  Maya Wiessman; Dorit Leshem; Moshe Yeshurun; Hagai Yavin; Zaza Iakobishvilli; Pia Raanani; Ran Kornowski; Eli I Lev; Mordehay Vaturi
Journal:  Cancer Med       Date:  2018-12-13       Impact factor: 4.452

7.  Effects of Early Intensive Insulin Therapy on Endothelial Progenitor Cells in Patients with Newly Diagnosed Type 2 Diabetes.

Authors:  Wei Zhang; Hongdong Wang; Fangcen Liu; Xiao Ye; Wenjuan Tang; Pengzi Zhang; Tianwei Gu; Dalong Zhu; Yan Bi
Journal:  Diabetes Ther       Date:  2021-12-11       Impact factor: 2.945

8.  Influence of insulin and glargine on outgrowth and number of circulating endothelial progenitor cells in type 2 diabetes patients: a partially double-blind, randomized, three-arm unicenter study.

Authors:  Dimitrios Oikonomou; Stefan Kopf; Rüdiger von Bauer; Zdenka Djuric; Rita Cebola; Anja Sander; Stefan Englert; Spiros Vittas; Asa Hidmark; Michael Morcos; Grigorios Korosoglou; Peter P Nawroth; Per M Humpert
Journal:  Cardiovasc Diabetol       Date:  2014-10-11       Impact factor: 9.951

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.